Immune system boost tested against rare, Tough-to-Treat cancers
NCT ID NCT04458922
Summary
This study is testing whether a drug called atezolizumab can help control advanced forms of two rare cancers: chondrosarcoma (bone cancer) and clear cell sarcoma (soft tissue cancer). The drug works by helping the patient's own immune system recognize and attack the cancer cells. The trial is for patients whose cancer cannot be cured by surgery or has spread, and it aims to see if the treatment can shrink tumors and slow the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL CHONDROSARCOMA, GRADE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Emory University Hospital Midtown
Atlanta, Georgia, 30308, United States
-
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, 30322, United States
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
-
NCI - Center for Cancer Research
Bethesda, Maryland, 20892, United States
-
National Cancer Institute Developmental Therapeutics Clinic
Bethesda, Maryland, 20892, United States
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
-
Siteman Cancer Center-South County
St Louis, Missouri, 63129, United States
-
UF Health Cancer Institute - Gainesville
Gainesville, Florida, 32610, United States
-
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
-
University Health Network-Princess Margaret Hospital
Toronto, Ontario, M5G 2M9, Canada
-
University of Pittsburgh Cancer Institute (UPCI)
Pittsburgh, Pennsylvania, 15232, United States
-
Vanderbilt University/Ingram Cancer Center
Nashville, Tennessee, 37232, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.